These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2574744)

  • 1. DTG and (+)-3-PPP inhibit a ligand-activated hyperpolarization in mammalian neurons.
    Bobker DH; Shen KZ; Surprenant A; Williams JT
    J Pharmacol Exp Ther; 1989 Dec; 251(3):840-5. PubMed ID: 2574744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]DTG and [3H](+)-3-PPP label pharmacologically distinct sigma binding sites in guinea pig brain membranes.
    Karbon EW; Naper K; Pontecorvo MJ
    Eur J Pharmacol; 1991 Jan; 193(1):21-7. PubMed ID: 1675607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the actions of phencyclidine and sigma ligands on CA1 hippocampal pyramidal neurons in the rat.
    Malouf AT; Swearengen E; Chavkin C
    Neuropharmacology; 1988 Nov; 27(11):1161-70. PubMed ID: 2849730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple vascular effects of sigma and PCP ligands: inhibition of amine uptake and contractile responses.
    Massamiri T; Duckles SP
    J Pharmacol Exp Ther; 1990 Apr; 253(1):124-9. PubMed ID: 2158542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,3-Di(2-tolyl)guanidine blocks nicotinic response in guinea pig myenteric neurons.
    Galligan JJ; Campbell BG; Kavanaugh MP; Weber E; North RA
    J Pharmacol Exp Ther; 1989 Oct; 251(1):169-74. PubMed ID: 2552073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol treatment differentially regulates [3H]DTG and [3H](+)-3-PPP labeled sigma binding sites.
    Bailey MA; Karbon EW
    Eur J Pharmacol; 1993 Aug; 240(2-3):243-50. PubMed ID: 7902283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of sigma receptors and responsiveness to guanine nucleotides following repeated exposure of rats to haloperidol: further evidence for multiple sigma binding sites.
    Itzhak Y; Stein I
    Brain Res; 1991 Dec; 566(1-2):166-72. PubMed ID: 1667608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of potassium currents by the sigma receptor ligand (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine in sympathetic neurons of the mouse isolated hypogastric ganglion.
    Kennedy C; Henderson G
    Neuroscience; 1990; 35(3):725-33. PubMed ID: 1974331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sigma ligand-induced emesis in the pigeon.
    Hudzik TJ
    Pharmacol Biochem Behav; 1992 Jan; 41(1):215-7. PubMed ID: 1347173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal stimulation of specific pathways in the rat hippocampus causes a reduction in radioligand binding to the haloperidol-sensitive sigma receptor.
    Connor MA; Chavkin C
    Exp Brain Res; 1991; 85(3):528-36. PubMed ID: 1680737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of rat cortical sigma receptors after subchronic administration of rimcazole and 1,3-di(2-tolyl)guanidine.
    Manallack DT; Beart PM
    Neuropharmacology; 1988 Nov; 27(11):1201-3. PubMed ID: 2849732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (125I)iodoazidococaine, a photoaffinity label for the haloperidol-sensitive sigma receptor.
    Kahoun JR; Ruoho AE
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1393-7. PubMed ID: 1311097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sigma-binding site ligands inhibit K+ currents in rat locus coeruleus neurons in vitro.
    Nguyen VH; Ingram SL; Kassiou M; Christie MJ
    Eur J Pharmacol; 1998 Nov; 361(1):157-63. PubMed ID: 9851553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination of (+)-3-PPP sites from DTG sites by FH-510, a novel potent sigma ligand, in rat brain.
    Chaki S; Tanaka M; Muramatsu M; Otomo S
    Eur J Pharmacol; 1993 Nov; 250(1):173-5. PubMed ID: 7907020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of sigma-ligands to C57BL/6 mouse brain membranes: effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of sigma-receptor subtypes.
    Itzhak Y; Stein I; Zhang SH; Kassim CO; Cristante D
    J Pharmacol Exp Ther; 1991 Apr; 257(1):141-8. PubMed ID: 1850463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sigma receptor ligands inhibit rat tail artery contractile responses by multiple mechanisms.
    Massamiri T; Duckles SP
    J Pharmacol Exp Ther; 1991 Oct; 259(1):22-9. PubMed ID: 1656019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An examination of the putative sigma-receptor in the mouse isolated vas deferens.
    Kennedy C; Henderson G
    Br J Pharmacol; 1989 Oct; 98(2):429-36. PubMed ID: 2555009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sigma binding sites in guinea-pig and rat brain membranes: G-protein interactions.
    Connick JH; Hanlon G; Roberts J; France L; Fox PK; Nicholson CD
    Br J Pharmacol; 1992 Nov; 107(3):726-31. PubMed ID: 1361872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characteristics of hyperambulation induced by the sigma ligand (+)-3-PPP in rats.
    Hirotsu I; Koyama M; Honbo N; Ohno T
    Jpn J Pharmacol; 1994 May; 65(1):1-7. PubMed ID: 7916383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for an anti-amnesic effect of JO 1784 in the rat: a potent and selective ligand for the sigma receptor.
    Earley B; Burke M; Leonard BE; Gouret CJ; Junien JL
    Brain Res; 1991 Apr; 546(2):282-6. PubMed ID: 1676927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.